This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →

Permanently Discontinued

PEGASYS

HOFFMANN-LA ROCHE LIMITED

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of PEGASYS in Canada?

Yes. PEGASYS 180MCG has an active shortage reported to Health Canada (last updated September 15, 2026).

Why is PEGASYS not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will PEGASYS be available again?

The manufacturer's estimated resolution date is September 30, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file1 product

Affected strength180MCG

Last updated2018-01-04

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

PEGASYS

HOFFMANN-LA ROCHE LIMITED

180MCG · DIN 02248078

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02248077

Strength

180MCG

Dosage Form

SOLUTION

Route

SUBCUTANEOUS

Active Ingredient

PEGINTERFERON ALFA-2A

Tier

Unrated

Last Updated

2018-01-04

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

PEGASYS has 2 shortage/discontinuation reports on file — this is one of them.

2026-09-15

Active Shortage

Disruption of the manufacture of the drug.

Other Products from HOFFMANN-LA ROCHE LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

162MG · DIN 02424770

162MG · DIN 02483327

200MG · DIN 02350106

400MG · DIN 02350114

80MG · DIN 02350092

DIN 02147440